Like I3C, DIM attenuated the DSS-induced colitis by inhibiting TNF-α, IL-6, IFN-γ, IL-10, iNOS, COX-2, NO, PGE2, myeloperoxidase activity (MPO), and NF-kB. This evidence concerns the gene IL6 and colitis.